Are angiotensin-converting enzyme inhibitors or angiotensin receptor blockers beneficial in normotensive atherosclerotic patients : a collaborative meta-analysis of randomized trials?
Angiotensin-converting enzyme inhibitors or ARB are beneficial in patients with, or at increased risk for, atherosclerotic disease even if their systolic pressure is <130 mmHg before treatment.
Joint line was adequately restored when computer navigation was carefully applied as a measuring tool for primary TKA. Knee joint deformity, leg alignment, gap balance, and implant type did not aid in predicting the joint line shift.